<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04664634</url>
  </required_header>
  <id_info>
    <org_study_id>STU00212981</org_study_id>
    <nct_id>NCT04664634</nct_id>
  </id_info>
  <brief_title>Therapeutic Swallow Sensor</brief_title>
  <official_title>Novel Sensor for Swallowing in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the development and early-stage validation of a wearable sensor&#xD;
      for dysphagia in patients with PD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project goal is the development and early stage validation of a wearable sensor for&#xD;
      dysphagia in patients with PD. The first phase of the program involves engineering goals&#xD;
      relating to increasing the battery life of this sensor to 48 hours between charges and&#xD;
      reducing the overall form factor size. The second phase of the program is to conduct focus&#xD;
      groups with PD patients to assess sensor usability, set up burden, and design feedback. The&#xD;
      third phase of the study will assess the feasibility of the sensor to detect and cue&#xD;
      swallowing in a small cohort of PD patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">August 14, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 14, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent agreement with Gold Standard</measure>
    <time_frame>1 year</time_frame>
    <description>Percent agreement between experimental sensor Gold standard (GS) respiratory inductance plethysmography (RIP) with Inductotrace System®, Ambulatory Monitoring)</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Dysphagia</condition>
  <condition>Parkinson Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Parkinson's Disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥21 years of age&#xD;
&#xD;
          -  PD patients of any severity&#xD;
&#xD;
          -  Evidence of mild to moderate oropharyngeal dysphagia as determined by an SLP&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients cannot safely swallow at least one bolus of liquid without risk of aspiration&#xD;
&#xD;
          -  End stage dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Abigail Nellis</last_name>
    <phone>(847) 467-8907</phone>
    <email>abigail.day@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cagla Kantarcigil</last_name>
    <email>cagla.kantarcigil@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abigail Nellis</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 6, 2020</study_first_submitted>
  <study_first_submitted_qc>December 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>December 6, 2020</last_update_submitted>
  <last_update_submitted_qc>December 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Shuai (Steve) Xu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

